These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11380913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
    Durand M, Sardesai S, McEvoy C.
    Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
    Brundage KL, Mohsini KG, Froese AB, Walker CR, Fisher JT.
    Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS, Ohlsson A, Halliday H, Shah VS.
    Cochrane Database Syst Rev; 2003 Mar; (2):CD002057. PubMed ID: 12804423
    [Abstract] [Full Text] [Related]

  • 9. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
    Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH.
    Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2001 Oct; (2):CD001145. PubMed ID: 11405975
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams.
    Kaempf JW, Campbell B, Sklar RS, Arduza C, Gallegos R, Zabari M, Brown A, McDonald JV.
    Pediatrics; 2003 Apr; 111(4 Pt 2):e534-41. PubMed ID: 12671173
    [Abstract] [Full Text] [Related]

  • 14. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS, Ohlsson A, Halliday H, Shah VS.
    Cochrane Database Syst Rev; 2003 Apr; (1):CD002058. PubMed ID: 12535425
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP, Blennow M, Soll RF.
    Cochrane Database Syst Rev; 2004 Apr; (3):CD003063. PubMed ID: 15266470
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2000 Apr; (2):CD001145. PubMed ID: 10796251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.